Latest Breaking News On - California trading down - Page 6 : comparemela.com

Piper Sandler reduced their price objective on Pacific Biosciences of California from $7.50 to $6.00 in a research report on Sunday.

United statesPacific biosciencesPiper sandlerHarbor investment advisoryFirst horizon advisors incCalifornia incCantor fitzgeraldCarret asset managementCanaccord genuity groupAd oxford clubCalifornia company profile get ratingGenuity groupCalifornia trading downPlay markets likeWhy thisFunds weigh in on pacific biosciences